Skip to content
healthcare.dev

CARBINOXAMINE MALEATE

NDC 69315-239, CARBINOXAMINE MALEATE, tablet, from Leading Pharma, LLC.

Product NDC
69315-239
Status
Listed
Labeler
Leading Pharma, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215476
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69315-239 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBINOXAMINE MALEATE6 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
69315-239-0169315023901100 TABLET in 1 BOTTLE (69315-239-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/02e13b55-2153-468e-a5bd-57dee062f47f

Use it

Look up 69315-239 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69315-239 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69315-239. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.